I agree to all those posters who said that there is no further news to wait for after the full data from the HSV-2 Phase 1 study are released this quarter.........
.......oh wait..... I forgot these items below. How silly of me to forget even though they were previous published a couple of times yesterday in this forum.
- Extending the use of CardioCel® for an expanded range of indications in cardiovascular surgery;
- Expanding regenerative tissue portfolio and explore the use of ADAPT® prepared tissue for additional surgical applications that have the potential to increase revenue in the future;
- Initial Asian market approval for CardioCel®;
- Initiation of HSV-2 Phase II; and
- Initiation of HPV Phase I.
- Forums
- ASX - By Stock
- AVR
- News: Admedus revenue up 7.09% for FY2014
News: Admedus revenue up 7.09% for FY2014, page-23
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.90 |
Change
-0.100(0.56%) |
Mkt cap ! $342.1M |
Open | High | Low | Value | Volume |
$18.00 | $18.00 | $17.75 | $11.68K | 651 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 600 | $17.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.99 | 39 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 600 | 17.750 |
1 | 26 | 17.660 |
1 | 26 | 17.650 |
1 | 200 | 17.560 |
1 | 500 | 17.550 |
Price($) | Vol. | No. |
---|---|---|
17.990 | 39 | 3 |
18.000 | 654 | 4 |
18.010 | 121 | 3 |
18.030 | 14 | 1 |
18.100 | 700 | 1 |
Last trade - 11.14am 15/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |